Table 2 Extended Sample set used to further validate MultiCoV-Ab performance.
Age group | ≤39 | 40–59 | ≥60 | Not available | ∑ | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | 299 (25.4%) | 241 (20.5%) | 475 (40.4%) | 161 (13.7%) | 1176 | ||||||||||||||
Sex | Male | Female | Male | Female | Male | Female | Male | Female | Not available | ||||||||||
n | 139 | (11.8%) | 160 | (13.6%) | 144 | (12.2%) | 97 | (8.2%) | 271 | (23.0%) | 204 | (17.3%) | 5 | (0.4%) | 3 | (0.3%) | 153 | (13.0%) | 1176 |
SARS-CoV-2 infected | 60 | (19.4%) | 51 | (16.5%) | 71 | (22.9%) | 63 | (20.3%) | 42 | (13.5%) | 17 | (5.5%) | 3 | (1.0%) | 3 | (1.0%) | 0 | (0.0%) | 310 |
hospitalized | 6 | (10.9%) | 2 | (3.6%) | 14 | (25.5%) | 6 | (10.9%) | 23 | (41.8%) | 4 | (7.3%) | 0 | (0.0%) | 0 | (0.0%) | 0 | (0.0%) | 55 |
non-hospitalized | 52 | (25.0%) | 43 | (20.7%) | 49 | (23.6%) | 43 | (20.7%) | 13 | (6.3%) | 8 | (3.8%) | 0 | (0.0%) | 0 | (0.0%) | 0 | (0.0%) | 208 |
hospitalization NA | 2 | (4.3%) | 6 | (12.8%) | 8 | (17.0%) | 14 | (29.8%) | 6 | (12.8%) | 5 | (10.6%) | 3 | (6.4%) | 3 | (6.4%) | 0 | (0.0%) | 47 |
SARS-CoV-2 uninfected | 79 | (9.1%) | 109 | (12.6%) | 73 | (8.4%) | 34 | (3.9%) | 229 | (26.4%) | 187 | (21.6%) | 2 | (0.2%) | 0 | (0.0%) | 153 | (17.7%) | 866 |
